Eszopiclone Tablet, Film Coated
Product Images NDC 70518-4361

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Eszopiclone (NDC 70518-4361). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Eszopiclone 2 mg film-coated tablets packaging label for 30 count. The label indicates the drug is a Schedule IV controlled substance with NDC 70518-4361-00. Manufactured by Camber Pharma, Inc., Piscataway, NJ, and repackaged by RemedyRepack Inc., Indiana, PA. The label includes storage instructions and a federal caution about drug transfer restrictions.*

FDA Label Image

Eszopiclonestructure (Eszopiclonestructure)

Chemical structure of Eszopiclone, the active ingredient in the medication Eszopiclone 2 mg oral film-coated tablets by RemedyRepack Inc., depicted as a molecular diagram showing its atomic and bonding arrangement including nitrogen, oxygen, chlorine, and carbon atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.